Licensing and partnering opportunities
These are some highlighted research projects ready now for partnering or licensing here at The Institute of Cancer Research – although there are opportunities to collaborate with our scientists across the full range of our research.
Contact the Business and Innovation office
If you'd like to speak to our researchers – or learn about the Innovation Gateway, a new incubator space in Sutton, South London, which offers unique opportunities to collaborate with us.
Opportunity: Antibody-derived small molecules and ‘macrodrug’ degraders
Commissioner: Professor Terence Rabbitts
Opportunity: A small molecule drug conjugate as a novel prodrug-activating platform
Commissioner: Professor Udai Banerji
Opportunity: AI-based multiplex image analysis of pathology slides (SANDI)
Commissioner: Professor Yinyin Yuan
Opportunity: Image/AI-driven cancer biomarker to measure immune environment
Commissioner: Professor Yinyin Yuan, Dr Khalid Abdul Jabbar
Opportunity: Predictive test for personalising breast cancer treatment
Commissioner: Professor Mitch Dowsett
Opportunity: Novel method for sequencing the T-cell receptor from degraded RNA
Commissioner: Dr Annie Baker
Opportunity: A potent, orally bioavailable clinical-stage inhibitor of MPS1 with potential as a treatment for a range of cancer types including triple negative breast cancer
Commissioner: Swen Hoelder
Opportunity: Novel non-invasive imaging tool for measuring tumour stiffness
Commissioner: Dr Emma Harris
Opportunity: Cancer biomarker for predicting response to drugs targeting mitotic checkpoint kinases and cell division
Commissioner: Professor Andrew Tutt, Professor Chris Lord, Professor Jonathon Pines
Opportunity: Discovering and developing small molecule inhibitors of ERAP1
Commissioner: Dr Esther Arwert
Opportunity: A novel test for predicting future cancer risk in patients with inflammatory bowel disease
Commissioner: Professor Trevor Graham
Opportunity: Targeting ART1 to overcome immune resistance in lung cancer treatment
Commissioner: Dr Erik Wennerberg
Opportunity: A deep-learning method to improve the analysis of MRI in clinical imaging
Commissioner: Dr Matthew Blackledge
Opportunity: Molecular subtyping and predictive test for personalising colorectal cancer
Commissioner: Professor Anguraj Sadanandam
Opportunity: Predictive test for personalising treatment of advanced sarcoma
Commissioner: Professor Paul Huang, Dr Maggie Cheang, Professor Robin Jones
Opportunity: Cancer vaccines or immunotherapy to tackle drug resistance
Commissioner: Dr Stephen Pettitt